These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1400299)

  • 1. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of high molecular weight kininogen to cultured human endothelial cells.
    van Iwaarden F; de Groot PG; Bouma BN
    J Biol Chem; 1988 Apr; 263(10):4698-703. PubMed ID: 2832403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation.
    Baird TR; Walsh PN
    J Biol Chem; 2002 Oct; 277(41):38462-7. PubMed ID: 12167623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
    Mahdi F; Shariat-Madar Z; Schmaier AH
    J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
    Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
    Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of coagulation factor XI to washed human platelets.
    Greengard JS; Heeb MJ; Ersdal E; Walsh PN; Griffin JH
    Biochemistry; 1986 Jul; 25(13):3884-90. PubMed ID: 3017409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.
    van der Graaf F; Greengard JS; Bouma BN; Kerbiriou DM; Griffin JH
    J Biol Chem; 1983 Aug; 258(16):9669-75. PubMed ID: 6604052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
    Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
    J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture.
    Lenich C; Pannell R; Gurewich V
    Thromb Haemost; 1995 Aug; 74(2):698-703. PubMed ID: 8585009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative interactions of factor IX and factor IXa with human platelets.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
    Sinha D; Koshy A; Seaman FS; Walsh PN
    J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
    Walsh PN; Bradford H; Sinha D; Piperno JR; Tuszynski GP
    J Clin Invest; 1984 May; 73(5):1392-9. PubMed ID: 6609171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic versus extrinsic coagulation. Kinetic considerations.
    Warn-Cramer BJ; Bajaj SP
    Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of clotting factors XI and IX in patients with acute myocardial infarction.
    Minnema MC; Peters RJ; de Winter R; Lubbers YP; Barzegar S; Bauer KA; Rosenberg RD; Hack CE; ten Cate H
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2489-93. PubMed ID: 11073857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipids accelerate factor IX activation by surface bound factor XIa.
    Mannhalter C; Schiffman S; Deutsch E
    Br J Haematol; 1984 Feb; 56(2):261-71. PubMed ID: 6607067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.